Tord Ekbom

5.4k total citations · 2 hit papers
27 papers, 3.8k citations indexed

About

Tord Ekbom is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Economics and Econometrics. According to data from OpenAlex, Tord Ekbom has authored 27 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 13 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Economics and Econometrics. Recurrent topics in Tord Ekbom's work include Blood Pressure and Hypertension Studies (20 papers), Hormonal Regulation and Hypertension (9 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Tord Ekbom is often cited by papers focused on Blood Pressure and Hypertension Studies (20 papers), Hormonal Regulation and Hypertension (9 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Tord Ekbom collaborates with scholars based in Sweden, France and United Kingdom. Tord Ekbom's co-authors include Lars Lindholm, Bengt Scherstén, Björn Dahlöf, L. Hansson, Ulf dé Fairé, Thomas Hedner, Lennart Hansson, Jan Lanke, François Gueyffier and Robert Fagard and has published in prestigious journals such as The Lancet, Circulation and Diabetes Care.

In The Last Decade

Tord Ekbom

27 papers receiving 3.5k citations

Hit Papers

Morbidity and mortality in the Swedish Trial in Old Patie... 1991 2026 2002 2014 1991 1999 400 800 1.2k

Peers

Tord Ekbom
Kimberley A. Eberlein United States
Tord Ekbom
Citations per year, relative to Tord Ekbom Tord Ekbom (= 1×) peers Kimberley A. Eberlein

Countries citing papers authored by Tord Ekbom

Since Specialization
Citations

This map shows the geographic impact of Tord Ekbom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tord Ekbom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tord Ekbom more than expected).

Fields of papers citing papers by Tord Ekbom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tord Ekbom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tord Ekbom. The network helps show where Tord Ekbom may publish in the future.

Co-authorship network of co-authors of Tord Ekbom

This figure shows the co-authorship network connecting the top 25 collaborators of Tord Ekbom. A scholar is included among the top collaborators of Tord Ekbom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tord Ekbom. Tord Ekbom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hedner, Thomas, Bengt Jönsson, Tord Ekbom, et al.. (2005). Cost analysis of different pharmacological treatment strategies in elderly hypertensives. Blood Pressure. 14(2). 107–113. 8 indexed citations
2.
Ekbom, Tord, Thomas Hedner, Jan Lanke, et al.. (2004). Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP‐Hypertension‐2. Blood Pressure. 13(3). 137–141. 40 indexed citations
3.
Lindholm, Lars, Harald Anderson, Tord Ekbom, et al.. (2001). Relation between drug treatment and cancer In hypertenslves in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial. The Lancet. 358(9281). 539–544. 85 indexed citations
4.
Lièvre, Michel, François Gueyffier, Tord Ekbom, et al.. (2000). Efficacy of diuretics and beta-blockers in diabetic hypertensive patients. Results from a meta-analysis. Diabetes Care. 23. 18 indexed citations
5.
Lindholm, Lars, Lennart Hansson, Tord Ekbom, et al.. (2000). Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients. Journal of Hypertension. 18(11). 1671–1675. 142 indexed citations
6.
Hansson, Lennart, Lars Lindholm, Tord Ekbom, et al.. (1999). Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. The Lancet. 354(9192). 1751–1756. 1020 indexed citations breakdown →
7.
Gueyffier, François, Jean‐Pierre Boissel, Stuart Pocock, et al.. (1999). Identification of Risk Factors in Hypertensive Patients. Circulation. 100(18). e88–94. 38 indexed citations
8.
Ekbom, Tord, Lars Lindholm, Jan Lanke, & Peter Nilsson‐Ehle. (1996). Decrease in high density lipoprotein cholesterol during prolonged storage. Scandinavian Journal of Clinical and Laboratory Investigation. 56(2). 97–101. 7 indexed citations
9.
Lindholm, Lars, Lennart Hansson, Tord Ekbom, et al.. (1996). The Swedish Trial in Old Patients with Hypertension-2 (STOP-Hypertension-2): A Progress Report. Blood Pressure. 5(5). 300–304. 33 indexed citations
10.
Lindholm, Lars, et al.. (1996). Changes in cardiovascular risk factors by combined pharmacological and nonpharmacological strategies: the main results of the CELL Study. Journal of Internal Medicine. 240(1). 13–22. 28 indexed citations
11.
Lindholm, Lars, et al.. (1995). The impact of health care advice given in primary care on cardiovascular risk. BMJ. 310(6987). 1105–1109. 59 indexed citations
12.
Ekbom, Tord, Lars Lindholm, Anders Odén, et al.. (1994). A 5‐year prospective, observational study of the withdrawal of antihypertensive treatment in elderly people. Journal of Internal Medicine. 235(6). 581–588. 45 indexed citations
13.
Dahlöf, Björn, Lennart Hansson, Lars Lindholm, et al.. (1993). STOP-Hypertension 2: A Prospective Intervention Trial of “Newer” versus “Older” Treatment Alternatives in Old Patients with Hypertension. Blood Pressure. 2(2). 136–141. 67 indexed citations
14.
Johannesson, Magnus, Björn Dahlöf, Lars Lindholm, et al.. (1993). The cost‐effectiveness of treating hypertension in elderly people—an analysis of the Swedish Trial in Old Patients with Hypertension (STOP Hypertension). Journal of Internal Medicine. 234(3). 317–323. 48 indexed citations
15.
Lindholm, Lars & Tord Ekbom. (1993). Hypertension in the Elderly. Clinical and Experimental Hypertension. 15(6). 1343–1352. 1 indexed citations
16.
Johannesson, Magnus, Lars Borgqúist, Peter Nilsson‐Ehle, et al.. (1993). The cost of screening for hypercholesterolaemia– results from a clinical trial in Swedish primary health care. Scandinavian Journal of Clinical and Laboratory Investigation. 53(7). 725–732. 13 indexed citations
17.
Dahlöf, Björn, et al.. (1993). Swedish Trial in Old Patients with Hypertension (Stop-Hypertension) Analyses Performed up to 1992. Clinical and Experimental Hypertension. 15(6). 925–939. 29 indexed citations
18.
Hansson, Lennart, et al.. (1991). Key learnings from the STOP-Hypertension study: An update on the progress of the ongoing Swedish study of antihypertensive treatment in the elderly. Cardiovascular Drugs and Therapy. 4(S6). 1253–1255. 6 indexed citations
19.
Bengnér, Urban, Tord Ekbom, Olof Johnell, & Bo E. Nilsson. (1990). Incidence of femoral and tibial shaft fractures: Epidemiology 1950–1983 in Malmö, Sweden. Acta Orthopaedica Scandinavica. 61(3). 251–254. 49 indexed citations
20.
Ekbom, Tord, Lars Lindholm, Anders Odén, et al.. (1988). Blood pressure does not predict mortality in the elderly. Journal of Hypertension. 6(4). S626–628. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026